
Kite Pharma
Biotechnology company developing and commercializing cell therapies for cancer treatment.
About
Kite Pharma is a biotechnology company focused on developing and commercializing innovative cancer immunotherapy products, primarily through genetically engineered autologous CAR T cell therapy. Founded in 2009, it was acquired by Gilead Sciences in 2017 and operates as a subsidiary dedicated to advancing personalized treatments in immuno-oncology.
Similar companies
A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.
Shares Biotechnology, Pharmaceuticals
A clinical-stage biopharmaceutical company developing novel immunotherapies.
Shares Biotechnology, Pharmaceuticals
Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes.
Shares Biotechnology, Pharmaceuticals
Developing novel immunotherapies and diagnostics for cancer.
Shares Biotechnology
Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.
Shares Oncology, Biotechnology
A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.
Shares Biotechnology, Pharmaceuticals
Key facts
- Website
- kitepharma.com
- Headquarters
- Santa Monica, United States
- Founded
- 2009
- Total funding
- $421M (Venture)
- Business model
- B2B
Funding rounds
Tech stack
Detected on kitepharma.com, last scanned 20 Oct 2026. Run your own scan
- Frontend
- Tailwind CSS, Bootstrap
- Analytics
- Google Tag Manager
- CDN
- Cloudflare
- Email provider
- Proofpoint
Kite Pharma scores 67. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Kite Pharma trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Kite Pharma is 91 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Kite Pharma raised?
Kite Pharma has raised a total of $421M in funding. The most recent round on record is Venture.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Kite Pharma

